The parliamentary hearing was scheduled for nine in the morning on the first Thursday of December, in the main chamber of the Shin-Yamato National Diet building. The room was designed to intimidate—vaulted ceilings, dark wood paneling, rows of leather chairs occupied by legislators who had spent their careers perfecting the art of looking concerned without actually doing anything. Television cameras lined the back wall, their red lights blinking in synchronized rhythm. The public gallery was packed with journalists, activists, and families of the deceased, their faces pale with the particular exhaustion of people who had been fighting for justice longer than they had ever imagined possible.
Rin Asakura sat in the front row of the gallery, a notebook open on her lap and a pen in her hand. She had not slept in three days. The story of Sakamoto Pharma had consumed every waking hour since the Higanbana facility raid—follow-up interviews, document analysis, coordination with prosecutors who were building the criminal case. The Phase One photograph still sat on her desktop, its coordinates still typed into her notes, but she had not yet acted on it. There was too much still to do here, in the world of public accountability.
Reiko Sakamoto entered the chamber at exactly nine-fifteen.
She wore a dark blue kimono, formal and dignified, her hair arranged in an elaborate style that spoke of tradition and authority. Her posture was perfect, her expression composed, her hands folded calmly in front of her. She looked like a woman attending a cultural ceremony, not a CEO facing questions about twenty deaths. Behind her walked a phalanx of lawyers—six of them, all in identical black suits, carrying briefcases that undoubtedly contained enough legal arguments to keep her out of prison for the rest of her natural life.
The committee chairman, a silver-haired legislator named Tanaka who had been in the Diet for thirty years, called the session to order. The charges were read into the record: criminal negligence, obstruction of justice, violation of the Pharmaceutical Affairs Law, and conspiracy to commit murder. Each charge was met with a brief nod from Sakamoto's lead attorney, who had already filed preliminary motions to dismiss all of them.
"As CEO of Sakamoto Pharma, you oversaw the MemoriClear clinical program," Chairman Tanaka said, his voice echoing through the chamber. "Can you explain to this committee how a lethal compound came to be administered to elderly patients under the guise of a dementia treatment?"
Sakamoto leaned toward the microphone. When she spoke, her voice was measured and clear, the voice of someone who had been trained in media management since the day she inherited the company from her father.
"I am devastated by what occurred at the Himawari Gardens facility," she said. "The actions of Dr. Kenji Mori and his research team were a betrayal of everything Sakamoto Pharma stands for. When I learned of the unauthorized Phase Zero trials, I immediately initiated an internal investigation and contacted the authorities."
"Unauthorized?" Rin whispered the word to herself, her pen pressing hard against the notebook page.
"According to our investigation, Dr. Mori concealed the true nature of the MemoriClear compound from company leadership. He operated a rogue research program using company resources without approval. We have provided documentation to the committee demonstrating that the Phase Zero trials were never authorized by the Sakamoto Pharma board of directors."
A legislator from the opposition party leaned forward. "Ms. Sakamoto, the committee has obtained server logs showing that your personal administrative account accessed the Higanbana system on a daily basis. You initiated a remote data purge on the morning of November 14th, the same day the facility was raided. How do you explain this?"
Sakamoto's expression did not change. "My account credentials were compromised. We believe Dr. Mori obtained my login information through a phishing attack on the corporate network. I had no knowledge of the data purge until after it occurred."
From the gallery, Rin watched the legislators react. Some of them nodded sympathetically—those who had received campaign contributions from Sakamoto Pharma, or whose districts housed the company's manufacturing facilities, or who simply believed that a woman of Sakamoto's stature could not possibly be involved in murder. Others looked skeptical. But skepticism was not enough. In a parliamentary hearing, the burden of proof fell on the accuser, and Sakamoto's lawyers had spent weeks constructing a narrative that placed all the blame on a single rogue physician.
The hearing continued for three hours. Witness after witness was called—regulatory officials who had approved the MemoriClear program, former Sakamoto Pharma employees who had raised concerns about the clinical trials, medical experts who testified about the mechanism of the microRNA compound. Through it all, Sakamoto sat motionless, her expression unchanged, her answers perfectly calibrated to admit nothing while appearing to cooperate fully.
At noon, the chairman called a recess. Rin slipped out of the gallery and found Hayashi waiting in the corridor, his face grim.
"She's going to walk," he said quietly. "The committee doesn't have the votes for a criminal referral. Too many members are in Sakamoto's pocket, and the ones who aren't are afraid of being sued for defamation."
"What about the evidence? The server logs? The data purge?"
"Circumstantial, her lawyers argue. The credentials were stolen. The purge was initiated remotely by an unknown party. Dr. Mori is refusing to testify against her—he's been offered a deal by someone, probably Sakamoto's legal team, and he's taking the fall for everything." Hayashi rubbed the back of his neck. "I've seen this before. The powerful ones, the ones at the top—they never get touched. It's always the subordinates who go to prison."
Rin looked back at the chamber doors. Through the frosted glass, she could see Sakamoto standing in the center of a cluster of lawyers, her kimono pristine, her expression serene. She was not a woman facing justice. She was a woman who had already won.
"The law isn't built for crimes like this," Rin said slowly. "Mori used a biological mechanism that conventional forensics couldn't detect. Sakamoto is using a legal mechanism that conventional prosecution can't touch. The murderers are a generation ahead of the system."
"That's the problem, isn't it?" Hayashi leaned against the wall. "We caught them, and it still might not matter."
---
The hearing resumed at two in the afternoon. The final witness was Shiro Nakamura, the Phase Zero survivor, his testimony recorded via video link from the hospital where he was still receiving treatment for neurological damage. His voice was weak but steady as he described the injections, the symptoms, the deaths of eleven other patients in his cohort.
"I watched them die," Nakamura said. "One by one. Tuesday injections, Wednesday supplement drinks, Thursday funerals. I kept records because I thought someone would come. Someone would investigate. Someone would care."
"And did anyone come?" the chairman asked.
"No. Not until Ms. Asakura. Not until her grandfather died and she started asking questions that no one else would ask." Nakamura paused, his image flickering on the screen. "The system failed us. Every part of it. The doctors who administered the injections. The regulators who approved the program. The police who dismissed the deaths as natural causes. Everyone who was supposed to protect us looked the other way."
In the gallery, Rin felt tears burning at the corners of her eyes. She blinked them away. She was a journalist. Journalists were not supposed to cry.
The chairman thanked Nakamura for his testimony and turned to Sakamoto for a final statement. The CEO rose, smoothing her kimono with practiced grace.
"I want to express my deepest apologies to the victims and their families," she said. "Sakamoto Pharma will establish a compensation fund of five billion yen to provide for those affected by Dr. Mori's actions. We will also implement new oversight protocols to ensure that nothing like this ever happens again. The safety of our patients has always been our highest priority, and we are committed to restoring the trust that has been broken."
Five billion yen. Rin did the math in her head. Twenty victims, plus the survivors like Nakamura. After legal fees and administrative costs, each family might receive a few million yen. The price of a human life, according to Sakamoto Pharma, was roughly equivalent to a mid-range sedan.
"And the criminal charges?" the chairman asked. "Will Sakamoto Pharma cooperate with the ongoing investigation into corporate responsibility?"
"Of course. We have already provided prosecutors with all relevant documents and will continue to assist in any way we can."
Rin watched the legislators nod approvingly. The hearing was winding down. The cameras were being repositioned for the post-hearing press conferences. The story was already being written by the major news outlets: CEO expresses regret, compensation fund established, company promises reform. The narrative was being closed, neatly and cleanly, with no one at the top held accountable for anything.
She stood up and walked out of the gallery.
---
Kai was waiting for her in the lobby of the Diet building, his laptop open on a bench and his fingers flying across the keyboard. He looked up when she approached, and his expression was troubled.
"I found something," he said. "While the hearing was going on, I was monitoring Sakamoto Pharma's internal network traffic. I know it's illegal, but I thought—"
"Show me."
He turned the laptop so she could see the screen. It displayed a series of encrypted messages, partially decrypted, their contents fragmented but still legible enough to understand.
*Phase One subjects transferred to Southern Islands facility... Phase Zero data successfully purged from Higanbana server... Legal team confident of no criminal liability... Begin Phase Two recruitment within six months...*
"Phase Two," Rin said. "They're already planning Phase Two."
"There's more." Kai clicked to another message. "This one was sent from Reiko Sakamoto's personal device. Not her work account—her personal phone. The encryption is different, harder to crack, but I got enough of it."
The message was dated three days ago. It was addressed to an unidentified recipient, someone whose email address was a string of numbers and letters that didn't correspond to any known domain.
*The parliamentary hearing will proceed as expected. Mori will accept full responsibility. Compensation fund will placate public sentiment. Recommend proceeding with Phase Two as planned. The delivery mechanism is refined—new trigger compound is undetectable by current screening methods. Recommend using the Southern Islands population for efficacy testing. No regulatory oversight in that jurisdiction. We can continue operations without interruption.*
Rin read the message three times. Each time, the words seemed to grow colder.
"She authorized everything," Kai said. "Not just Phase Zero. She's been directing the entire operation. Mori was a subordinate. Sakamoto is the architect."
"We knew that. We suspected it."
"Suspecting and proving are different things. This message—it's proof. Direct evidence of criminal intent. If we can get this to the prosecutors, they can charge her with conspiracy to commit murder."
"Can we get it to the prosecutors? Legally?"
Kai hesitated. "I obtained it by hacking into Sakamoto Pharma's internal network. That's a violation of the Computer Fraud Act. Any evidence obtained through illegal means is inadmissible in Shin-Yamato courts."
Rin leaned back against the bench, the weight of the situation pressing down on her. They had the evidence. They had the proof. And they couldn't use it, because the laws that were supposed to protect citizens had been written before anyone imagined a world where crimes could be committed through encrypted servers and biological delivery systems.
"So Sakamoto walks free," she said. "Because she committed her crimes using technology that the legal system doesn't understand."
"That's one way to look at it." Kai closed his laptop. "But there's another way."
"What do you mean?"
"You're a journalist. You don't need to follow the rules of evidence. You can publish whatever you want, as long as you can verify it. And this message—" he tapped the laptop, "—this message is verifiable. The encryption signatures prove it came from Sakamoto's device. The timeline matches the internal investigation. Anyone with the right technical expertise can confirm it's genuine."
Rin understood what he was suggesting. "If I publish this, I'm burning my source. I'm admitting that we obtained the information illegally."
"You're publishing the truth. And sometimes the truth matters more than the method."
She thought about her grandfather. She thought about the notebook filled with numbers, the message he had left for someone to find. She thought about Shiro Nakamura, sitting alone in a hospital room, waiting for a justice that the legal system was not designed to deliver.
"Send me the decrypted files," she said. "All of them."
---
The story ran the next morning, on the front page of the Shin-Yamato Times, under the headline: "SAKAMOTO ORDERED PHASE ZERO KILLINGS—SECRET MESSAGES REVEAL CEO'S DIRECT INVOLVEMENT."
The article was six thousand words long, accompanied by reproductions of the decrypted messages, technical explanations of how the encryption had been broken, and a detailed timeline showing Reiko Sakamoto's direct involvement in every stage of the MemoriClear program. Rin had worked through the night, writing and revising, checking every fact three times, knowing that her career—and possibly her freedom—depended on getting every detail right.
The reaction was immediate.
By noon, the parliamentary committee had reconvened in emergency session. By evening, prosecutors had announced a new investigation into Reiko Sakamoto's personal involvement in the MemoriClear deaths. By the following morning, Sakamoto Pharma's stock had fallen forty percent, and three members of the board of directors had resigned.
And yet.
When the prosecutors filed charges, they charged Sakamoto with corporate negligence—not murder, not conspiracy. The maximum penalty was a fine and a suspended prison sentence. The legal system, constrained by laws written for a simpler era, simply did not have the tools to prosecute a crime that had been committed through encrypted messages and biological triggers.
"A slap on the wrist," Hayashi said, sitting in Rin's newsroom cubicle two weeks after the story broke. "Twenty people dead, and she gets a fine she can pay with her pocket change."
"It's more than we had before," Rin said. "The company is being dissolved. The MemoriClear program is shut down. The Phase Two facility in the Southern Islands is being investigated by international authorities."
"And Sakamoto herself? She'll retire quietly to her estate in the mountains, write a memoir about her struggles, and spend the rest of her life being invited to speak at business conferences about the importance of ethical leadership." Hayashi shook his head. "I've been a detective for twenty-five years, and I still can't get used to the way the system protects the people at the top."
Rin looked at her computer screen. The Phase One photograph was still there, the coordinates still typed into her notes. She had not forgotten about them.
"There might be another way," she said slowly.
"What do you mean?"
"Sakamoto isn't protected from everything. The Shin-Yamato legal system couldn't touch her because the evidence was obtained illegally, and the crimes were too technically sophisticated for the existing statutes. But what about international law?"
Hayashi frowned. "The Southern Islands facility isn't in Shin-Yamato jurisdiction."
"Exactly. It's in international territory. And if Sakamoto was planning to conduct human trials there, without regulatory oversight, that might violate international conventions on medical ethics. There are treaties. There are courts in the International Justice System that have broader evidentiary standards than Shin-Yamato courts."
"You're talking about taking this case to an international tribunal."
"I'm talking about following the evidence wherever it leads."
Hayashi was quiet for a moment. Then he reached into his jacket and pulled out a folded piece of paper. "I thought you might say something like that. This arrived at the precinct yesterday. It's from a contact I have in the Foreign Ministry. Someone who owes me a favor."
Rin unfolded the paper. It was a diplomatic cable, partially redacted, sent from the Shin-Yamato embassy in the Southern Islands. The cable described unusual activity at a remote research facility—shipments of medical equipment, hiring of local staff, requests for construction permits that had been fast-tracked through channels that didn't exist in any public record.
"This is the Phase One facility," Rin said. "The one from the photograph."
"It's bigger than we thought. According to this cable, there are at least two hundred people living at the facility. Local villagers, recruited as test subjects. They've been told it's a medical charity, providing free healthcare to underserved communities."
"Two hundred people." Rin felt the familiar cold weight settle in her stomach. "And they're all being dosed with the MemoriClear compound."
"Phase Two, just like the message said. A larger trial population, in a jurisdiction where no one is watching." Hayashi met her eyes. "If you want to go after them, you'll need help. International help. And you'll be going up against not just Sakamoto, but the entire system that protected her."
Rin looked at the photograph on her desktop. The concrete building surrounded by jungle. The sign partially obscured by foliage. Two hundred people who didn't know they were test subjects.
"When do we leave?" she asked.
---
Three days later, Rin Asakura boarded a plane to the Southern Islands.
She brought a single suitcase, a laptop filled with research files, and a letter of introduction from an international human rights organization that had agreed to support her investigation. Kai had promised to continue monitoring Sakamoto Pharma's communications from Shin-Yamato, providing technical support from half a world away. Hayashi had pulled strings with his Foreign Ministry contact to ensure that Rin would have at least minimal diplomatic protection in case things went wrong.
As the plane lifted off from Shin-Yamato International Airport, Rin looked out the window at the city receding below—the glass towers, the financial district, the Himawari Gardens building that still stood three blocks from Sakamoto Pharma headquarters. Her grandfather was buried in a cemetery on the outskirts of the city, in a grave she had visited only once since the funeral. She had promised herself she would go back when the story was finished. When justice had been done.
The story was not finished yet.
On her laptop, she opened a new document and began to type. The working title was "The Zero Trial," but she was already thinking of a better one. Something that captured what she had learned in the past weeks—about crime and punishment, about systems that protected the powerful, about the gap between what the law could see and what the law could punish.
She thought about her grandfather's notebook. The numbers he had written when words had failed him. The message he had left for someone to find.
*They test tomorrow. Please let someone find this.*
She had found it. And she would keep finding it, for as long as it took, until every person responsible for the MemoriClear deaths had been held accountable—not just in the court of public opinion, but in courts that had the power to deliver real justice.
The plane banked south, toward the islands, toward the jungle, toward a facility that didn't exist on any public map. Below, the ocean stretched endlessly, blue and deep and indifferent.
Somewhere beneath that ocean, Rin knew, there were answers. And she was going to find them.
No comments yet. Be the first to comment!